Andre Thierry, MD of University Pierre et Marie Curie @UPMC discusses pembrolizumab vs. chemotherapy for microsatellite instability-high/mismatch repair deficient metastatic colorectal cancer: the phase 3 KEYNOTE-177 study presented at this year’s virtual ASCO.
Read here: https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.18_suppl.LBA4
Advertisement